Boston Scientific Corporation
name
Boston Scientific Corporation
id
BSX
summary
Boston Scientific Corporation (BSC), incorporated in Delaware, is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices used in various interventional medical specialties. Founded on June 29, 1979, in Watertown, Massachusetts, it is known for the development of the Taxus Stent, a drug-eluting stent for opening clogged arteries, and the EMBLEM subcutaneous implantable defibrillator (S-ICD) following the acquisition of Cameron Health in June 2012. As of 2023, it operates in more than 100 countries, employs approximately 48,000 people, and reported revenues of US$14.24 billion. The company has a history of significant acquisitions, technological innovations, and expansion into various medical fields, including interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, and more.